| Autor: |
Braslow NM; Center for Health Care Policy and Evaluation, United HealthCare, Minneapolis, MN 55440, USA., Shatin D, McCarthy DB, Newcomer LN |
| Jazyk: |
angličtina |
| Zdroj: |
The American journal of managed care [Am J Manag Care] 1998 Sep 25; Vol. 4 Spec No, pp. SP139-50. |
| Abstrakt: |
With the profusion of new medical technology, managed care organizations are faced with the challenge of determining which medical devices and services warrant health benefits coverage. To aid in this decision-making process, managed care companies turn to technology assessment, a process that differs from the Food and Drug Administration's review of medical devices. Health plans typically use a structured approach to implementing coverage requirements in employer group benefits contracts and use technology assessment to evaluate the scientific evidence of effectiveness to support coverage decisions. Also important is the societal context for decisions regarding coverage for new technologies and the options being considered by policy makers for accountability in technology assessment by private insurers and health plans. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
